BLADDER CANCER AND DEBATE ON TRIMODAL THERAPY (TMT) FOR BLADDER PRESERVATION

Article Sidebar

PDF
Published: May 11, 2018
DOI: https://doi.org/10.14295/aimj.v2i4.30

Main Article Content

Antonio Marlos Duarte de Melo
FMJ - CE/BRAZIL
José Angelo Araújo Sampaio
FMJ - CE/Brazil
Ana Beatriz Callou Sampaio Neves
FMJ - CE/Brazil
Isabella Callou Sampaio Neves
Lucas Leimig Telles Parente
Maria Valéria Leimig Telles
Mikael Vieira da Silva

Abstract

Abstract: Bladder Cancer is one of the most common types of malignant neoplasms that affects both men and women. The surgery considered standard for the treatment of invasive tumor is Radical Cystectomy, which causes undesirable morbidity in the postoperative period on affected patients. Radical Transurethral Resection (TRU), associated with Chemotherapy and Radiotherapy, together form the Trimodal Therapy (TTM), which can demonstrate satisfactory results in the approach of the patient with invasive tumor with lower morbidity and well-timed survival rate, in a short time.

 

Keywords: Bladder Cancer; Radical Cystectomy; Transurethral Resection; Trimodal Therapy.

Metrics

Metrics Loading ...

Article Details

How to Cite
Melo, A. M. D. de, Sampaio, J. A. A., Neves, A. B. C. S., Neves, I. C. S., Parente, L. L. T., Telles, M. V. L., & Silva, M. V. da. (2018). BLADDER CANCER AND DEBATE ON TRIMODAL THERAPY (TMT) FOR BLADDER PRESERVATION. Amadeus International Multidisciplinary Journal, 2(4), 52–56. https://doi.org/10.14295/aimj.v2i4.30
Issue
Vol. 2 No. 4 (2018)
Section
Article

This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. 

Author Biography

Antonio Marlos Duarte de Melo, FMJ - CE/BRAZIL

Professora Adjunta.

References

References

Jacobs, B., Lee, C. and Montie, J. (2010). Bladder Cancer in 2010: How Far have We Come?.CA: A Cancer Journal for Clinicians, 60(4), pp.244-272.

James, N., Hussain, S., Hall, E., Jenkins, P., Tremlett, J., Rawlings, C., Crundwell, M., Sizer, B.,Sreenivasan, T.,Hendron, C., Lewis, R., Waters, R. and Huddart, R. (2012). Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer. New England Journal of Medicine, 366(16), pp.1477-1488.

Premo, C., Apolo, A., Agarwal, P. and Citrin, D. (2015). Trimodality Therapy in Bladder Cancer. Urologic Clinics of North America, 42(2), pp.169-180.

Ploussard, G., Daneshmand, S., Efstathiou, J., Herr, H., James, N., Rödel, C., Shariat, S., Shipley, W., Sternberg, C., Thalmann, G. and Kassouf, W. (2014). Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review. European Urology, 66(1), pp.120-137.

Gakis, G., Efstathiou, J., Lerner, S., Cookson, M., Keegan, K., Guru, K., Shipley, W., Heidenreich, A., Schoenberg, M., Sagaloswky, A., Soloway, M. and Stenzl, A. (2013). ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder. European Urology, 63(1), pp.45-57.

Kulkarni, G., Hermanns, T., Wei, Y., Bhindi, B., Satkunasivam, R., Athanasopoulos, P., Bostrom, P., Kuk, C., Li, K., Templeton, A., Sridhar, S., van der Kwast, T., Chung, P., Bristow, R., Milosevic, M., Warde, P., Fleshner, N., Jewett, M., Bashir, S. and Zlotta, A. (2017). Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic. Journal of Clinical Oncology, pp.JCO.2016.69.232.

Mitin, T. (2017). Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: No. International brazjurol, 43(2), pp.188-191.

Solsona, E., Iborra, I., Collado, A., Rubio-Briones, J., Casanova, J. And Calatrava, A. (2010). Feasibility of Radical Transurethral Resection as Monotherapy for Selected Patients With Muscle Invasive Bladder Cancer. The Journal of Urology, 184(2), pp.475-481.